Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole

被引:21
作者
Koener, Beryl [1 ]
Focant, Marylene C. [1 ]
Bosier, Barbara [1 ]
Maloteaux, Jean-Marie [1 ]
Hermans, Emmanuel [1 ]
机构
[1] Catholic Univ Louvain, Inst Neurosci Ions, Grp Neuropharmacol, B-1200 Brussels, Belgium
关键词
(-)-3-PPP; G protein; Inducible expression; N-methyl-D-glucamine; DOPAMINE-D-2; RECEPTOR; ANTIPSYCHOTIC-DRUG; FUNCTIONAL SELECTIVITY; BINDING; OPC-14597; SODIUM; ACTIVATION; EXPRESSION; EFFICACY; MODULATION;
D O I
10.1016/j.pnpbp.2011.08.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical efficacy of aripiprazole in the treatment of psychosis relies on a partial agonism at D-2 receptors. As. the expression of this receptor differs physiologically between pre- and post-synaptic sites and is affected by pathological conditions or pharmacological treatments, it appears difficult to predict the clinical response to partial agonists. In addition, the response to this novel antipsychotic was shown to depend on the cell-line and the pathway analyzed, suggesting a functional selective profile at the D-2 receptor. This study aims at examining the influence of receptor density and ionic environment on the pharmacological properties of aripiprazole. A cell line was developed in which the expression of the recombinant D-2 receptor can be tightly manipulated using doxycycline and sodium butyrate. The potency and efficacy of aripiprazole and other reference D-2 receptor ligands were examined in [S-35]GTP gamma S binding assays, in buffers containing either NaCl or N-methyl-D-glucamine (NMDG) which is proposed to enhance G protein coupling. Increasing the density of D-2 receptors considerably enhanced the [S-35]GTP gamma S binding induced by dopamine and the full agonist NPA. In maximally induced cells, the agonist properties of the partial agonist (-)-3-PPP was revealed in a buffer containing NaCl, whereas the response to aripiprazole was not evidenced. Substituting NMDG for NaCl promoted the response to dopamine and (-)3-PPP and was proven efficient to reveal the partial agonist profile of aripiprazole. While NMDG substitution for NaCl strongly enhanced receptor-G protein coupling, these ionic manipulations are likely to influence receptor conformations, thereby modulating the activation of signaling pathways. Our data obtained with partial agonists acting at the D-2 receptor suggest that these changes in the experimental conditions could contribute to reveal the functional selective profile of GPCR ligands. They also emphasize that the properties of functional selective ligands do not only depend on receptor density but also on the surrounding environment which likely differs between brain structures. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 70
页数:11
相关论文
共 47 条
[1]   Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties [J].
Bardin, Laurent ;
Kleven, Mark S. ;
Barret-Grevoz, Catherine ;
Depoortere, Ronan ;
Newman-Tancredi, Adrian .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) :1869-1879
[2]   Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance [J].
Bosier, Barbara ;
Hermans, Emmanuel .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) :438-446
[3]   Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors [J].
Burris, KD ;
Molski, TF ;
Xu, C ;
Ryan, E ;
Tottori, K ;
Kikuchi, T ;
Yocca, FD ;
Molinoff, PB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :381-389
[4]   Study of a Synthetic Human Olfactory Receptor 17-4: Expression and Purification from an Inducible Mammalian Cell Line [J].
Cook, Brian L. ;
Ernberg, Karin E. ;
Chung, Hyeyoun ;
Zhang, Shuguang .
PLOS ONE, 2008, 3 (08)
[5]   Agonist regulation of D2 dopamine receptor/G protein interaction -: Evidence for agonist selection of G protein subtype [J].
Cordeaux, Y ;
Nickolls, SA ;
Flood, LA ;
Graber, SG ;
Strange, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28667-28675
[6]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[7]   Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists [J].
Emmerson, PJ ;
McKinzie, JH ;
Surface, PL ;
Suter, TM ;
Mitch, CH ;
Statnick, MA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) :121-130
[8]   Pharmacological analysis of dopamine stimulation of [S-35]-GTP gamma S binding via human D-2short and D-2long dopamine receptors expressed in recombinant cells [J].
Gardner, B ;
Hall, DA ;
Strange, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1544-1550
[9]   Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells [J].
Gazi, L ;
Bobirnac, I ;
Danzeisen, M ;
Schüpbach, E ;
Langenegger, D ;
Sommer, B ;
Hoyer, D ;
Tricklebank, M ;
Schoeffter, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (03) :613-620
[10]   Enhanced striatal dopamine D2 receptor-induced [35S]GTPγS binding after haloperidol treatment [J].
Geurts, M ;
Hermans, E ;
Maloteaux, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 382 (02) :119-127